article thumbnail

Piloting the PQA Specialty Pharmacy Turnaround Time Quality Measure

PQA

The use of specialty medicine has grown rapidly in recent decades, fueling parallel growth in the number of specialty pharmacies that serve patients who are prescribed specialty medications. Results of this work were published in the Journal of Managed Care & Specialty Pharmacy in October 2022.

article thumbnail

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

pharmaphorum

A similar inflection point now faces the specialty pharmaceutical industry. Along their journey, specialty pharma patients interact with a series of siloed institutions: clinics, specialty pharmacies, copay program vendors, patient assistance programs, nurses, etc. The time to cross that bridge has passed.

HIPAA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NASP 2022 Reveals a Pharmacy Landscape Shifting to Specialty

Omnicell

Kristen Dowd Director, Pharmacy Management Services, Omnicell If the 2022 NASP (National Association of Specialty Pharmacy) Annual Meeting and Expo is any indication, we are approaching a time when specialty pharmacy simply becomes pharmacy – when complex, high-touch biologics become nearly as ubiquitous as their broad-spectrum counterparts.

article thumbnail

APPE Rotation with PQA

PQA

PQA offers a competitive Advanced Pharmacy Practice Experiential (APPE) Rotation for pharmacy students, which provides experiential learning opportunities in non-profit association management, medication use quality education, communications, research and performance measurement.

article thumbnail

Rare Disease Day and a Focus on Quality

PQA

Ensuring the quality of medication use is critically important for rare disease patients, payers, clinicians, specialty pharmacies and everyone with a role in the care process. The economic burden of rare disease reached nearly $1 trillion in 2019, and the average drug approved under the Orphan Drug Act costs nearly $120,000 per year.

article thumbnail

Celebrating PQA in 2024!

PQA

Successfully piloting pharmacy measure concepts focused on blood pressure and A1c improvement and control. Successfully piloting PQA’s endorsed measure focused on specialty pharmacy turnaround time. Beyond the member resource library, PQA members can stay updated with our frequent email and newsletter communications.

article thumbnail

PQA Welcomes 11 New Members

PQA

Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.